nifedipine has been researched along with Ventricular Dysfunction, Left in 24 studies
Nifedipine: A potent vasodilator agent with calcium antagonistic action. It is a useful anti-anginal agent that also lowers blood pressure.
Ventricular Dysfunction, Left: A condition in which the LEFT VENTRICLE of the heart was functionally impaired. This condition usually leads to HEART FAILURE; MYOCARDIAL INFARCTION; and other cardiovascular complications. Diagnosis is made by measuring the diminished ejection fraction and a depressed level of motility of the left ventricular wall.
| Excerpt | Relevance | Reference |
|---|---|---|
| "We sought to determine the effect of nifedipine gastrointestinal therapeutic system (GITS) or atenolol on ischemic left ventricular dysfunction induced by mental stress." | 9.08 | Effects of therapy with nifedipine GITS or atenolol on mental stress-induced ischemic left ventricular dysfunction. ( Andrews, TC; Carlson, W; Cummings, N; Friedman, R; Jacobs, S; MacCallum, G; Mannting, F; Muller, JE; Parker, JD; Stone, PH; Tofler, GH, 1998) |
| " Sublingual nifedipine but not nitroglycerin attenuates this process and suggests that altered calcium homeostasis may play a role in left ventricular dysfunction that occurs after exercise-induced ischemia." | 5.08 | Effects of nifedipine and nitroglycerin on left ventricular systolic dysfunction and impaired diastolic filling after exercise-induced ischemia in humans. ( Ikram, S; Longaker, RA; Prince, CR; Stoddard, MF; Wagner, SG, 1996) |
| "We sought to determine the effect of nifedipine gastrointestinal therapeutic system (GITS) or atenolol on ischemic left ventricular dysfunction induced by mental stress." | 5.08 | Effects of therapy with nifedipine GITS or atenolol on mental stress-induced ischemic left ventricular dysfunction. ( Andrews, TC; Carlson, W; Cummings, N; Friedman, R; Jacobs, S; MacCallum, G; Mannting, F; Muller, JE; Parker, JD; Stone, PH; Tofler, GH, 1998) |
| "Nifedipine did not produce any effect on LV regional wall motion in group 1, but it induced significant changes in LV regional wall motion in seven patients in group 2." | 2.68 | Relation between exercise-induced left ventricular wall motion abnormalities and coronary artery disease in hypertensive patients: effects of blood pressure normalization. ( Berti, M; Maltagliati, A; Muratori, M; Passaretti, B; Pepi, M; Tamborini, G; Tavasci, E, 1997) |
| " We report two cases that developed cerebrovascular and cardiovascular adverse events associated with aggressive treatment of increased blood pressure by the use of sublingual nifedipine capsule." | 1.32 | Adverse events associated with aggressive treatment of increased blood pressure. ( Akay, S; Ayrik, C; Cevik, AA; Yanturali, S, 2004) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 8 (33.33) | 18.2507 |
| 2000's | 14 (58.33) | 29.6817 |
| 2010's | 2 (8.33) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Zimmer, J | 1 |
| Hawlitschek, C | 1 |
| Rabald, S | 1 |
| Hagendorff, A | 1 |
| Zimmer, HG | 1 |
| Rassler, B | 1 |
| Ye, P | 1 |
| Wu, CE | 1 |
| Sheng, L | 1 |
| Li, H | 1 |
| Ago, T | 1 |
| Yang, Y | 1 |
| Zhai, P | 1 |
| Sadoshima, J | 1 |
| Möllhoff, T | 1 |
| Schmidt, C | 1 |
| Van Aken, H | 1 |
| Berendes, E | 1 |
| Buerkle, H | 1 |
| Marmann, P | 1 |
| Reinbold, T | 1 |
| Prenger-Berninghoff, R | 1 |
| Tjan, TD | 1 |
| Scheld, HH | 1 |
| Deng, MC | 1 |
| Plante, E | 1 |
| Couet, J | 1 |
| Gaudreau, M | 1 |
| Dumas, MP | 1 |
| Drolet, MC | 1 |
| Arsenault, M | 1 |
| Yanturali, S | 1 |
| Akay, S | 1 |
| Ayrik, C | 1 |
| Cevik, AA | 1 |
| Cleland, JG | 1 |
| Huan Loh, P | 1 |
| Freemantle, N | 1 |
| Clark, AL | 1 |
| Coletta, AP | 1 |
| Scheuble, A | 1 |
| Vahanian, A | 1 |
| Higashikuni, Y | 1 |
| Sata, M | 1 |
| Nagai, R | 1 |
| Scognamiglio, R | 1 |
| Negut, C | 1 |
| Palisi, M | 1 |
| Fasoli, G | 1 |
| Dalla-Volta, S | 1 |
| Bashore, TM | 1 |
| Yaoita, H | 1 |
| Yamaki, T | 1 |
| Mizugami, H | 1 |
| Sakamoto, N | 1 |
| Kawamura, K | 1 |
| Ujiie, Y | 1 |
| Maehara, K | 1 |
| Maruyama, Y | 1 |
| Bagate, K | 1 |
| Meiring, JJ | 1 |
| Gerlofs-Nijland, ME | 1 |
| Cassee, FR | 1 |
| Wiegand, H | 1 |
| Osornio-Vargas, A | 1 |
| Borm, PJ | 1 |
| Gupta, N | 1 |
| Dalmia, S | 1 |
| Deka, D | 1 |
| Mittal, S | 1 |
| Pagel, PS | 1 |
| Warltier, DC | 1 |
| Schön, HR | 1 |
| Stoddard, MF | 1 |
| Wagner, SG | 1 |
| Ikram, S | 1 |
| Longaker, RA | 1 |
| Prince, CR | 1 |
| Pepi, M | 1 |
| Maltagliati, A | 1 |
| Berti, M | 1 |
| Muratori, M | 1 |
| Tavasci, E | 1 |
| Passaretti, B | 1 |
| Tamborini, G | 1 |
| Grandi, AM | 1 |
| Marchesi, E | 1 |
| Bertolini, A | 1 |
| Finardi, G | 1 |
| Venco, A | 1 |
| White, CM | 1 |
| Andrews, TC | 1 |
| Parker, JD | 1 |
| Jacobs, S | 1 |
| Friedman, R | 1 |
| Cummings, N | 1 |
| MacCallum, G | 1 |
| Mannting, F | 1 |
| Tofler, GH | 1 |
| Carlson, W | 1 |
| Muller, JE | 1 |
| Stone, PH | 1 |
| Bîrsan, T | 1 |
| Kranz, A | 1 |
| Mares, P | 1 |
| Artemiou, O | 1 |
| Taghavi, S | 1 |
| Zuckermann, A | 1 |
| Klepetko, W | 1 |
| Novaro, GM | 1 |
| Rodriguez, LL | 1 |
| Palmieri, V | 1 |
| Devereux, RB | 1 |
4 reviews available for nifedipine and Ventricular Dysfunction, Left
| Article | Year |
|---|---|
Aortic insufficiency: defining the role of pharmacotherapy.
Topics: Adrenergic beta-Antagonists; Angiotensin-Converting Enzyme Inhibitors; Aortic Valve Insufficiency; H | 2005 |
Medical treatment of chronic valvular regurgitation.
Topics: Angiotensin-Converting Enzyme Inhibitors; Aortic Valve Insufficiency; Chronic Disease; Humans; Isoqu | 1995 |
Calcium channel blockers in left ventricular dysfunction or congestive heart failure.
Topics: Amlodipine; Calcium Channel Blockers; Clinical Trials as Topic; Diltiazem; Felodipine; Heart Failure | 1997 |
Angiotensin converting enzyme inhibition and dihydropyridine calcium channel blockade in the treatment of left ventricular hypertrophy in arterial hypertension.
Topics: Angiotensin-Converting Enzyme Inhibitors; Animals; Antihypertensive Agents; Atenolol; Calcium Channe | 2002 |
5 trials available for nifedipine and Ventricular Dysfunction, Left
| Article | Year |
|---|---|
Potential protective effect of long-term therapy with Xuezhikang on left ventricular diastolic function in patients with essential hypertension.
Topics: Aged; Biological Products; Blood Flow Velocity; C-Reactive Protein; Calcium Channel Blockers; Case-C | 2009 |
Myocardial ischaemia in patients with impaired left ventricular function undergoing coronary artery bypass grafting--milrinone versus nifedipin.
Topics: Aged; Anesthesia, General; Calcium Channel Blockers; Coronary Artery Bypass; Coronary Disease; Creat | 2002 |
Effects of nifedipine and nitroglycerin on left ventricular systolic dysfunction and impaired diastolic filling after exercise-induced ischemia in humans.
Topics: Adult; Aged; Calcium Channel Blockers; Echocardiography; Exercise Test; Female; Hemodynamics; Humans | 1996 |
Relation between exercise-induced left ventricular wall motion abnormalities and coronary artery disease in hypertensive patients: effects of blood pressure normalization.
Topics: Aged; Blood Pressure; Calcium Channel Blockers; Coronary Angiography; Coronary Disease; Echocardiogr | 1997 |
Effects of therapy with nifedipine GITS or atenolol on mental stress-induced ischemic left ventricular dysfunction.
Topics: Adrenergic beta-Antagonists; Adult; Aged; Atenolol; Cross-Over Studies; Diastole; Double-Blind Metho | 1998 |
15 other studies available for nifedipine and Ventricular Dysfunction, Left
| Article | Year |
|---|---|
Effects of late-onset and long-term captopril and nifedipine treatment in aged spontaneously hypertensive rats: Echocardiographic studies.
Topics: Animals; Antihypertensive Agents; Blood Pressure; Calcium Channel Blockers; Captopril; Drug Evaluati | 2015 |
Nifedipine inhibits cardiac hypertrophy and left ventricular dysfunction in response to pressure overload.
Topics: Algorithms; Animals; Blood Pressure; Calcium Channel Blockers; Calcium-Calmodulin-Dependent Protein | 2010 |
Left ventricular response to sustained volume overload from chronic aortic valve regurgitation in rats.
Topics: Animals; Aortic Valve Insufficiency; Calcium Channel Blockers; Echocardiography; Hypertrophy, Left V | 2003 |
Adverse events associated with aggressive treatment of increased blood pressure.
Topics: Administration, Oral; Aged; Aged, 80 and over; Brain Ischemia; Capsules; Chronic Disease; Female; He | 2004 |
Clinical trials update from the European Society of Cardiology: SENIORS, ACES, PROVE-IT, ACTION, and the HF-ACTION trial.
Topics: Adrenergic beta-Antagonists; Antibiotic Prophylaxis; Benzopyrans; Ethanolamines; Heart Failure; Huma | 2004 |
Reversible left ventricular hypertrophy after tako-tsubo-like cardiomyopathy.
Topics: Aged; Aspirin; Benzimidazoles; Biphenyl Compounds; Cardiomyopathy, Dilated; Chest Pain; Drug Therapy | 2005 |
Long-term survival and functional results after aortic valve replacement in asymptomatic patients with chronic severe aortic regurgitation and left ventricular dysfunction.
Topics: Adult; Aortic Valve Insufficiency; Chronic Disease; Combined Modality Therapy; Drug Administration S | 2005 |
Afterload reduction in chronic aortic regurgitation: it sure seems like a good idea.
Topics: Aortic Valve Insufficiency; Drug Administration Schedule; Heart Valve Prosthesis Implantation; Human | 2005 |
A case of recurrent chest pain with reversible left ventricular dysfunction and ST segment elevation on electrocardiogram.
Topics: Acetylcholine; Aged; Cardiac Catheterization; Chest Pain; Cineangiography; Coronary Circulation; Ele | 2005 |
Ambient particulate matter affects cardiac recovery in a Langendorff ischemia model.
Topics: Air Pollutants; Animals; Calcium; Calcium Channel Blockers; Calcium Channels; Coronary Circulation; | 2006 |
Successful maternal and fetal outcome in a pregnancy with type V Takayasu's aortoarteritis.
Topics: Adult; Antihypertensive Agents; Arterial Occlusive Diseases; Calcium Channel Blockers; Diuretics; Fe | 2008 |
Mechanical consequences of calcium channel modulation during volatile anesthetic-induced left ventricular systolic and diastolic dysfunction.
Topics: 3-Pyridinecarboxylic acid, 1,4-dihydro-2,6-dimethyl-5-nitro-4-(2-(trifluoromethyl)phenyl)-, Methyl e | 1994 |
Effect of sublingual nifedipine on left ventricular diastolic dysfunction in hypertensives: echo-Doppler study at rest and during handgrip.
Topics: Administration, Sublingual; Adult; Calcium Channel Blockers; Diastole; Echocardiography, Doppler; Ha | 1996 |
Transient left ventricular failure following bilateral lung transplantation for pulmonary hypertension.
Topics: Adult; Alprostadil; Antihypertensive Agents; Cardiac Output, Low; Cardiotonic Agents; Catheterizatio | 1999 |
Left ventricular outflow tract obstruction unmasked by nifedipine: a therapeutic pitfall in the management of chronic aortic regurgitation.
Topics: Aortic Valve Insufficiency; Chronic Disease; Echocardiography; Humans; Male; Middle Aged; Nifedipine | 2001 |